Alzinova AB (publ) (STO:ALZ)
0.7400
-0.0100 (-1.33%)
Jan 21, 2026, 5:12 PM CET
Alzinova AB Revenue
Alzinova AB had revenue of 6.04M SEK in the quarter ending September 30, 2025, with 4.66% growth. This brings the company's revenue in the last twelve months to 26.12M, up 50.14% year-over-year. In the year 2024, Alzinova AB had annual revenue of 16.81M, down -15.41%.
Revenue (ttm)
26.12M
Revenue Growth
+50.14%
P/S Ratio
3.00
Revenue / Employee
5.22M
Employees
5
Market Cap
78.24M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 16.81M | -3.06M | -15.41% |
| Dec 31, 2023 | 19.87M | 3.24M | 19.49% |
| Dec 31, 2022 | 16.63M | -688.74K | -3.98% |
| Dec 31, 2021 | 17.32M | 2.42M | 16.27% |
| Dec 31, 2020 | 14.90M | 8.09M | 118.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.67B |
| Elekta AB | 17.57B |
| Asker Healthcare Group AB | 16.41B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |